biotech IP trends

Biotechnology companies increasingly view intellectual property strategy as a central pillar of competitive advantage, particularly as innovation cycles accelerate across gene therapy, biologics, and precision medicine platforms. In the United States, strong patent portfolios remain essential for protecting scientific observations, securing investor confidence, and supporting long-term commercialization strategies. As biotechnology research becomes more complex and … Read more